Xencor (XNCR) Stock
Xencor (XNCR) closed at $34.50 on Nov 17, 2026; its Tenet Score is 40 of 100 against 340 Healthcare peers.
23 figures withheld by our checks. Each blank figure names its reason.
Key stats
- Close
- $34.50
- Nov 17, 2026
- Market cap
- $2.7B
- share price × the latest quarter's diluted weighted-average share count (vendor)
- 52-week range
- 10.38 – 40.60
- low → high · as of close, Nov 16, 2026
- Tenet Score
- 40/100
- Weak · 340 Healthcare peers
Industry: Drugs
Xencor Inc scores 40/100. Weak. Strongest on financial health, growth is the soft spot versus 340 Healthcare peers.
Tenet Score · vs sector
n=340Factor grades
Price
The whole report, at a glance · every card is a live peek, click any to open the section
- ✕ Buffett Quality
- ✕ Piotroski F-Score
- ✕ Graham Defensive
- ✕ Quality Compounder
- ✓ Drawdown Context
- ✓ Reversal Evidence
13F flows & insider trades land here.
Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that target…
Similar-sized companies in Drugs
The 10 companies in this industry closest in market cap, as of Nov 16, 2026.
| Company | Tenet Score | Market cap |
|---|---|---|
| Xeris Biopharma Holdings IncXERS | 48 | $3.1B |
| Adma Biologics IncADMA | 72 | $3.0B |
| Ideaya Biosciences IncIDYA | 57 | $2.9B |
| Vericel CorpVCEL | 61 | $2.9B |
| Denali Therapeutics IncDNLI | 54 | $2.9B |
| HUTCHMED (China) LimitedHCM | 61 | $2.6B |
| Arcus Biosciences IncRCUS | 31 | $2.4B |
| Neogen Corp.NEOG | 45 | $2.4B |
| Regencell Bioscience Holdings LtdRGC | 31 | $2.3B |
| NewAmsterdam Pharma Company NVNAMS | 58 | $2.3B |
Common questions
What sector and industry is Xencor in?
Xencor is in the Healthcare sector and the Drugs industry.
What is Xencor's Tenet Score?
Xencor's Tenet Score is 40 out of 100, ranked against 340 Healthcare peers as of Nov 16, 2026.




